Clinical Trial Update: IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors

View source ↗

Summary

The clinical trial evaluating the impact of hyperkalemia on therapy with renin-angiotensin-aldosterone system inhibitors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• Renin-angiotensin-aldosterone system inhibitors

Snippet

Sponsor: Portsmouth Hospitals NHS Trust | Conditions: Hyperkalemia | Status: WITHDRAWN